IndexIQ Advisors’s Abiomed Inc ABMD Stock Holding History

IndexIQ Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$279K	Sell	845 -4	-0.5%	-$1.23K	0.01%	995
2021 Q4	$305K	Sell	849 -19	-2%	-$6.42K	0.01%	937
2021 Q3	$283K	Buy	868 +20	+2%	+$6.78K	0.01%	994
2021 Q2	$265K	Buy	848 +45	+6%	+$13.8K	0.01%	999
2021 Q1	$256K	Buy	803 +186	+30%	+$59.5K	0.01%	977
2020 Q4	$200K	Buy	617 +289	+88%	+$79.9K	0.01%	910
2020 Q3	$91K	Buy	328 +201	+158%	+$57.9K	﹤0.01%	936
2020 Q2	$31K	Buy	+127	New	+$25.5K	﹤0.01%	983
2020 Q1	–	Sell	-15	Closed	-$3K	–	1156
2019 Q4	$3K	Buy	+15	New	+$2.78K	﹤0.01%	793

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

IndexIQ Advisors's ABMD Position: Q1 2022 in Review

IndexIQ Advisors reduced its Abiomed Inc (ABMD) stake by 0.47% in Q1 2022, selling an estimated $1.23K and leaving 845 shares worth $279K. The position accounts for 0.01% of the portfolio, ranked #995.

IndexIQ Advisors first reported a position in ABMD in Q4 2019 and has held it in 9 quarters since. The position peaked at $305K in Q4 2021. 500 funds tracked by Wall St. Rank hold ABMD as of Q1 2022.

IndexIQ Advisors held 845 shares of Abiomed Inc worth $279K as of Q1 2022.
IndexIQ Advisors sold 4 Abiomed Inc shares in Q1 2022, an estimated $1.23K.
Abiomed Inc made up 0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #995 holding.
IndexIQ Advisors first reported a position in Abiomed Inc in Q4 2019 and has held it in 9 quarters since.
IndexIQ Advisors's Abiomed Inc position peaked at $305K in Q4 2021.
500 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.